FDA Releases Guidance for Industry on Cancer Drug and Biological Products Clinical Data in Marketing Applications

Summary

The Food and Drug Administration (FDA) has made available a guidance document outlining recommendations for the collection of clinical data to support marketing claims for cancer treatments in new drug applications, biologics license applications, or applications for supplemental indications.